<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20230711003245&amp;fc=20230708114047&amp;utm_medium=rss&amp;v=2.17.9.post6+86293ac
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20230711003245&amp;fc=20230708114047&amp;utm_medium=rss&amp;v=2.17.9.post6+86293ac" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.17.9.post6+86293ac)</generator>
<language>en</language>
<lastbuilddate>Tue, 11 Jul 2023 04:32:47 +0000</lastbuilddate>
<pubDate>Mon, 10 Jul 2023 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>Correction to: Treatment Strategies for Cardiomyopathy in Children: A Scientific Statement From the American Heart Association</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37428834/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230711003245&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Jul 11;148(2):e3. doi: 10.1161/CIR.0000000000001170. Epub 2023 Jul 10.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37428834/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230711003245&v=2.17.9.post6+86293ac">37428834</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001170>10.1161/CIR.0000000000001170</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37428834</guid>
<pubDate>Mon, 10 Jul 2023 06:00:00 -0400</pubDate>
<dc:date>2023-07-10</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: Treatment Strategies for Cardiomyopathy in Children: A Scientific Statement From the American Heart Association</dc:title>
<dc:identifier>pmid:37428834</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001170</dc:identifier>
</item>
<item>
<title>New Chapter in the PCSK9 Book: Oral Inhibition of PCSK9 Binding to the LDL Receptor With a Macrocyclic Peptide</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37428833/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230711003245&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Jul 11;148(2):159-161. doi: 10.1161/CIRCULATIONAHA.123.065407. Epub 2023 Jul 10.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37428833/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230711003245&v=2.17.9.post6+86293ac">37428833</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065407>10.1161/CIRCULATIONAHA.123.065407</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37428833</guid>
<pubDate>Mon, 10 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>Ulf Landmesser</dc:creator>
<dc:creator>Umidakhon Makhmudova</dc:creator>
<dc:date>2023-07-10</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>New Chapter in the PCSK9 Book: Oral Inhibition of PCSK9 Binding to the LDL Receptor With a Macrocyclic Peptide</dc:title>
<dc:identifier>pmid:37428833</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.065407</dc:identifier>
</item>
<item>
<title>Letter by Teng et al Regarding Article, "Direct Reprogramming Improves Cardiac Function and Reverses Fibrosis in Chronic Myocardial Infarction"</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37428832/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230711003245&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Jul 11;148(2):170-171. doi: 10.1161/CIRCULATIONAHA.123.064097. Epub 2023 Jul 10.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37428832/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230711003245&v=2.17.9.post6+86293ac">37428832</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064097>10.1161/CIRCULATIONAHA.123.064097</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37428832</guid>
<pubDate>Mon, 10 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>Zhenqing Teng</dc:creator>
<dc:creator>Xiang Ma</dc:creator>
<dc:creator>Yitong Ma</dc:creator>
<dc:date>2023-07-10</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Letter by Teng et al Regarding Article, "Direct Reprogramming Improves Cardiac Function and Reverses Fibrosis in Chronic Myocardial Infarction"</dc:title>
<dc:identifier>pmid:37428832</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.064097</dc:identifier>
</item>
<item>
<title>Myocardial Neprilysin Is Increased in Hypertrophic Cardiomyopathy</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37428831/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230711003245&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Jul 11;148(2):167-169. doi: 10.1161/CIRCULATIONAHA.123.064153. Epub 2023 Jul 10.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37428831/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230711003245&v=2.17.9.post6+86293ac">37428831</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064153>10.1161/CIRCULATIONAHA.123.064153</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37428831</guid>
<pubDate>Mon, 10 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>David W J Armstrong</dc:creator>
<dc:creator>Lance A Riley</dc:creator>
<dc:creator>Yan Ru Su</dc:creator>
<dc:creator>Ashish S Shah</dc:creator>
<dc:creator>Tarek Absi</dc:creator>
<dc:creator>Deepak K Gupta</dc:creator>
<dc:creator>Quinn S Wells</dc:creator>
<dc:creator>D Marshall Brinkley</dc:creator>
<dc:creator>Lynne W Stevenson</dc:creator>
<dc:creator>W David Merryman</dc:creator>
<dc:date>2023-07-10</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Myocardial Neprilysin Is Increased in Hypertrophic Cardiomyopathy</dc:title>
<dc:identifier>pmid:37428831</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.064153</dc:identifier>
</item>
<item>
<title>Highlights From the &lt;em>;Circulation&lt;/em>; Family of Journals</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37428830/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230711003245&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Jul 11;148(2):162-166. doi: 10.1161/CIRCULATIONAHA.123.065701. Epub 2023 Jul 10.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37428830/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230711003245&v=2.17.9.post6+86293ac">37428830</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065701>10.1161/CIRCULATIONAHA.123.065701</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37428830</guid>
<pubDate>Mon, 10 Jul 2023 06:00:00 -0400</pubDate>
<dc:date>2023-07-10</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Highlights From the &lt;em>;Circulation&lt;/em>; Family of Journals</dc:title>
<dc:identifier>pmid:37428830</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.065701</dc:identifier>
</item>
<item>
<title>Response by Sadahiro et al to Letter Regarding Article, "Direct Reprogramming Improves Cardiac Function and Reverses Fibrosis in Chronic Myocardial Infarction"</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37428829/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230711003245&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Jul 11;148(2):172-173. doi: 10.1161/CIRCULATIONAHA.123.065132. Epub 2023 Jul 10.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37428829/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230711003245&v=2.17.9.post6+86293ac">37428829</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065132>10.1161/CIRCULATIONAHA.123.065132</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37428829</guid>
<pubDate>Mon, 10 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>Taketaro Sadahiro</dc:creator>
<dc:creator>Hidenori Tani</dc:creator>
<dc:creator>Masaki Ieda</dc:creator>
<dc:date>2023-07-10</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Response by Sadahiro et al to Letter Regarding Article, "Direct Reprogramming Improves Cardiac Function and Reverses Fibrosis in Chronic Myocardial Infarction"</dc:title>
<dc:identifier>pmid:37428829</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.065132</dc:identifier>
</item>
<item>
<title>Value-Based Payment for Clinicians Treating Cardiovascular Disease: A Policy Statement From the American Heart Association</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37427456/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230711003245&amp;v=2.17.9.post6+86293ac
      <description>Clinician payment is transitioning from fee-for-service to value-based payment, with reimbursement tied to health care quality and cost. However, the overarching goals of value-based payment-to improve health care quality, lower costs, or both-have been largely unmet. This policy statement reviews the current state of value-based payment and provides recommended best practices for future design and implementation. The policy statement is divided into sections that detail different aspects of...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Jul 10. doi: 10.1161/CIR.0000000000001143. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Clinician payment is transitioning from fee-for-service to value-based payment, with reimbursement tied to health care quality and cost. However, the overarching goals of value-based payment-to improve health care quality, lower costs, or both-have been largely unmet. This policy statement reviews the current state of value-based payment and provides recommended best practices for future design and implementation. The policy statement is divided into sections that detail different aspects of value-based payment: (1) key program design features (patient population, quality measurement, cost measurement, and risk adjustment), (2) the role of equity during design and evaluation, (3) adjustment of payment, and (4) program implementation and evaluation. Each section introduces the topic, describes important considerations, and lists examples from existing programs. Each section includes recommended best practices for future program design. The policy statement highlights 4 key themes for successful value-based payment. First, programs should carefully weigh the incentives between lowering cost and improving quality of care and ensure that there is adequate focus on quality of care. Second, the expansion of value-based payment should be a tool for improving equity, which is central to quality of care and should be a focal point of program design and evaluation. Third, value-based payment should continue to move away from fee for service toward more flexible funding that allows clinicians to focus resources on the interventions that best help patients. Last, successful programs should find ways to channel clinicians' intrinsic motivation to improve their performance and the care for their patients. These principles should guide the future development of clinician value-based payment models.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37427456/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230711003245&v=2.17.9.post6+86293ac">37427456</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001143>10.1161/CIR.0000000000001143</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37427456</guid>
<pubDate>Mon, 10 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>Alexander T Sandhu</dc:creator>
<dc:creator>Paul A Heidenreich</dc:creator>
<dc:creator>William Borden</dc:creator>
<dc:creator>Steven A Farmer</dc:creator>
<dc:creator>P Michael Ho</dc:creator>
<dc:creator>Gmerice Hammond</dc:creator>
<dc:creator>Janay C Johnson</dc:creator>
<dc:creator>Rishi K Wadhera</dc:creator>
<dc:creator>Jason H Wasfy</dc:creator>
<dc:creator>Cathie Biga</dc:creator>
<dc:creator>Edwin Takahashi</dc:creator>
<dc:creator>Khamal D Misra</dc:creator>
<dc:creator>Karen E Joynt Maddox</dc:creator>
<dc:creator>American Heart Association Advocacy Coordinating Committee</dc:creator>
<dc:date>2023-07-10</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Value-Based Payment for Clinicians Treating Cardiovascular Disease: A Policy Statement From the American Heart Association</dc:title>
<dc:identifier>pmid:37427456</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001143</dc:identifier>
</item>
<item>
<title>Multiomics of Tissue Extracellular Vesicles Identifies Unique Modulators of Atherosclerosis and Calcific Aortic Valve Stenosis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37427430/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230711003245&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: The first comparative proteomics study of human carotid artery plaques and calcified aortic valves identifies unique drivers of atherosclerosis versus aortic valve stenosis and implicates EVs in advanced cardiovascular calcification. We delineate a vesiculomics strategy to isolate, purify, and study protein and RNA cargoes from EVs entrapped in fibrocalcific tissues. Integration of vesicular proteomics and transcriptomics by network approaches revealed novel roles for tissue EVs in...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Jul 10. doi: 10.1161/CIRCULATIONAHA.122.063402. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Fewer than 50% of patients who develop aortic valve calcification have concomitant atherosclerosis, implying differential pathogenesis. Although circulating extracellular vesicles (EVs) act as biomarkers of cardiovascular diseases, tissue-entrapped EVs are associated with early mineralization, but their cargoes, functions, and contributions to disease remain unknown.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Disease stage-specific proteomics was performed on human carotid endarterectomy specimens (n=16) and stenotic aortic valves (n=18). Tissue EVs were isolated from human carotid arteries (normal, n=6; diseased, n=4) and aortic valves (normal, n=6; diseased, n=4) by enzymatic digestion, (ultra)centrifugation, and a 15-fraction density gradient validated by proteomics, CD63-immunogold electron microscopy, and nanoparticle tracking analysis. Vesiculomics, comprising vesicular proteomics and small RNA-sequencing, was conducted on tissue EVs. TargetScan identified microRNA targets. Pathway network analyses prioritized genes for validation in primary human carotid artery smooth muscle cells and aortic valvular interstitial cells.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Disease progression drove significant convergence (<i>P</i>&lt;0.0001) of carotid artery plaque and calcified aortic valve proteomes (2318 proteins). Each tissue also retained a unique subset of differentially enriched proteins (381 in plaques; 226 in valves; q&lt;0.05). Vesicular gene ontology terms increased 2.9-fold (<i>P</i>&lt;0.0001) among proteins modulated by disease in both tissues. Proteomics identified 22 EV markers in tissue digest fractions. Networks of proteins and microRNA targets changed by disease progression in both artery and valve EVs revealed shared involvement in intracellular signaling and cell cycle regulation. Vesiculomics identified 773 proteins and 80 microRNAs differentially enriched by disease exclusively in artery or valve EVs (q&lt;0.05); multiomics integration found tissue-specific EV cargoes associated with procalcific Notch and Wnt signaling in carotid arteries and aortic valves, respectively. Knockdown of tissue-specific EV cargoes <i>FGFR2</i>, <i>PPP2CA</i>, and <i>ADAM17</i> in human carotid artery smooth muscle cells and <i>WNT5A</i>, <i>APP</i>, and <i>APC</i> in human aortic valvular interstitial cells significantly modulated calcification.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: The first comparative proteomics study of human carotid artery plaques and calcified aortic valves identifies unique drivers of atherosclerosis versus aortic valve stenosis and implicates EVs in advanced cardiovascular calcification. We delineate a vesiculomics strategy to isolate, purify, and study protein and RNA cargoes from EVs entrapped in fibrocalcific tissues. Integration of vesicular proteomics and transcriptomics by network approaches revealed novel roles for tissue EVs in modulating cardiovascular disease.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37427430/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230711003245&v=2.17.9.post6+86293ac">37427430</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.122.063402>10.1161/CIRCULATIONAHA.122.063402</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37427430</guid>
<pubDate>Mon, 10 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>Mark C Blaser</dc:creator>
<dc:creator>Fabrizio Buffolo</dc:creator>
<dc:creator>Arda Halu</dc:creator>
<dc:creator>Mandy E Turner</dc:creator>
<dc:creator>Florian Schlotter</dc:creator>
<dc:creator>Hideyuki Higashi</dc:creator>
<dc:creator>Lorena Pantano</dc:creator>
<dc:creator>Cassandra L Clift</dc:creator>
<dc:creator>Louis A Saddic</dc:creator>
<dc:creator>Samantha K Atkins</dc:creator>
<dc:creator>Maximillian A Rogers</dc:creator>
<dc:creator>Tan Pham</dc:creator>
<dc:creator>Amélie Vromman</dc:creator>
<dc:creator>Eugenia Shvartz</dc:creator>
<dc:creator>Galina K Sukhova</dc:creator>
<dc:creator>Silvia Monticone</dc:creator>
<dc:creator>Giovanni Camussi</dc:creator>
<dc:creator>Simon C Robson</dc:creator>
<dc:creator>Simon C Body</dc:creator>
<dc:creator>Jochen D Muehlschlegel</dc:creator>
<dc:creator>Sasha A Singh</dc:creator>
<dc:creator>Masanori Aikawa</dc:creator>
<dc:creator>Elena Aikawa</dc:creator>
<dc:date>2023-07-10</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Multiomics of Tissue Extracellular Vesicles Identifies Unique Modulators of Atherosclerosis and Calcific Aortic Valve Stenosis</dc:title>
<dc:identifier>pmid:37427430</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.122.063402</dc:identifier>
</item>
<item>
<title>Assessment of the Cardiac Noncoding Transcriptome by Single-Cell RNA Sequencing Identifies &lt;em>;FIXER&lt;/em>;, a Conserved Profibrogenic Long Noncoding RNA</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37427428/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230711003245&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: Our results demonstrated that lncRNA expression is sufficient to identify the various cell types composing the mammalian heart. Focusing on cardiac fibroblasts and their derivatives, we identified lncRNAs uniquely expressed in myofibroblasts. In particular, the lncRNA FIXER represents a novel therapeutic target for cardiac fibrosis.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Jul 10. doi: 10.1161/CIRCULATIONAHA.122.062601. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Cardiac fibroblasts have crucial roles in the heart. In particular, fibroblasts differentiate into myofibroblasts in the damaged myocardium, contributing to scar formation and interstitial fibrosis. Fibrosis is associated with heart dysfunction and failure. Myofibroblasts therefore represent attractive therapeutic targets. However, the lack of myofibroblast-specific markers has precluded the development of targeted therapies. In this context, most of the noncoding genome is transcribed into long noncoding RNAs (lncRNAs). A number of lncRNAs have pivotal functions in the cardiovascular system. lncRNAs are globally more cell-specific than protein-coding genes, supporting their importance as key determinants of cell identity.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: In this study, we evaluated the value of the lncRNA transcriptome in very deep single-cell RNA sequencing. We profiled the lncRNA transcriptome in cardiac nonmyocyte cells after infarction and probed heterogeneity in the fibroblast and myofibroblast populations. In addition, we searched for subpopulation-specific markers that can constitute novel targets in therapy for heart disease.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: We demonstrated that cardiac cell identity can be defined by the sole expression of lncRNAs in single-cell experiments. In this analysis, we identified lncRNAs enriched in relevant myofibroblast subpopulations. Selecting 1 candidate we named <i>FIXER</i> (fibrogenic <i>LOX</i>-locus enhancer RNA), we showed that its silencing limits fibrosis and improves heart function after infarction. <i>FIXER</i> mechanistically associates with CBX4, an E3 SUMO (small ubiquitin-like modifier) protein ligase and a transcription factor, target CBX4 to the promoter of the transcription factor RUNX1 to regulate its expression and thereby the whole fibrogenic gene program. <i>FIXER</i> is conserved in humans, supporting its translational value.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Our results demonstrated that lncRNA expression is sufficient to identify the various cell types composing the mammalian heart. Focusing on cardiac fibroblasts and their derivatives, we identified lncRNAs uniquely expressed in myofibroblasts. In particular, the lncRNA <i>FIXER</i> represents a novel therapeutic target for cardiac fibrosis.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37427428/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230711003245&v=2.17.9.post6+86293ac">37427428</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.122.062601>10.1161/CIRCULATIONAHA.122.062601</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37427428</guid>
<pubDate>Mon, 10 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>Parisa Aghagolzadeh</dc:creator>
<dc:creator>Isabelle Plaisance</dc:creator>
<dc:creator>Riccardo Bernasconi</dc:creator>
<dc:creator>Thomas A Treibel</dc:creator>
<dc:creator>Carlos Pulido Quetglas</dc:creator>
<dc:creator>Tania Wyss</dc:creator>
<dc:creator>Leonore Wigger</dc:creator>
<dc:creator>Mohamed Nemir</dc:creator>
<dc:creator>Alexandre Sarre</dc:creator>
<dc:creator>Panagiotis Chouvardas</dc:creator>
<dc:creator>Rory Johnson</dc:creator>
<dc:creator>Arantxa González</dc:creator>
<dc:creator>Thierry Pedrazzini</dc:creator>
<dc:date>2023-07-10</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Assessment of the Cardiac Noncoding Transcriptome by Single-Cell RNA Sequencing Identifies &lt;em>;FIXER&lt;/em>;, a Conserved Profibrogenic Long Noncoding RNA</dc:title>
<dc:identifier>pmid:37427428</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.122.062601</dc:identifier>
</item>
<item>
<title>Person-Centered Models for Cardiovascular Care: A Review of the Evidence: A Scientific Statement From the American Heart Association</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37427418/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230711003245&amp;v=2.17.9.post6+86293ac
      <description>Cardiovascular disease remains the leading cause of death and disability in the United States and globally. Disease burden continues to escalate despite technological advances associated with improved life expectancy and quality of life. As a result, longer life is associated with multiple chronic cardiovascular conditions. Clinical guidelines provide recommendations without considering prevalent scenarios of multimorbidity and health system complexities that affect practical adoption. The...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Jul 10. doi: 10.1161/CIR.0000000000001141. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Cardiovascular disease remains the leading cause of death and disability in the United States and globally. Disease burden continues to escalate despite technological advances associated with improved life expectancy and quality of life. As a result, longer life is associated with multiple chronic cardiovascular conditions. Clinical guidelines provide recommendations without considering prevalent scenarios of multimorbidity and health system complexities that affect practical adoption. The diversity of personal preferences, cultures, and lifestyles that make up one's social and environmental context is often overlooked in ongoing care planning for symptom management and health behavior support, hindering adoption and compromising patient outcomes, particularly in groups at high risk. The purpose of this scientific statement was to describe the characteristics and reported outcomes in existing person-centered care delivery models for selected cardiovascular conditions. We conducted a scoping review using Ovid MEDLINE, Embase.com, Web of Science, CINAHL Complete, Cochrane Central Register of Controlled Trials through Ovid, and ClinicalTrials.gov from 2010 to 2022. A range of study designs with a defined aim to systematically evaluate care delivery models for selected cardiovascular conditions were included. Models were selected on the basis of their stated use of evidence-based guidelines, clinical decision support tools, systematic evaluation processes, and inclusion of the patient's perspective in defining the plan of care. Findings reflected variation in methodological approach, outcome measures, and care processes used across models. Evidence to support optimal care delivery models remains limited by inconsistencies in approach, variation in reimbursement, and inability of health systems to meet the needs of patients with chronic, complex cardiovascular conditions.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37427418/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230711003245&v=2.17.9.post6+86293ac">37427418</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001141>10.1161/CIR.0000000000001141</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37427418</guid>
<pubDate>Mon, 10 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>Laura P Rossi</dc:creator>
<dc:creator>Bradi B Granger</dc:creator>
<dc:creator>Jeffrey T Bruckel</dc:creator>
<dc:creator>Deborah L Crabbe</dc:creator>
<dc:creator>Lucinda J Graven</dc:creator>
<dc:creator>Kimberly S Newlin</dc:creator>
<dc:creator>Megan M Streur</dc:creator>
<dc:creator>Maya K Vadiveloo</dc:creator>
<dc:creator>Benita Jeanne Walton-Moss</dc:creator>
<dc:creator>Bruce A Warden</dc:creator>
<dc:creator>Annabelle Santos Volgman</dc:creator>
<dc:creator>Melissa Lydston</dc:creator>
<dc:creator>American Heart Association Complex Cardiovascular Patient and Family Care Committee of the Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; and Council on Quality of Care and Outcomes Research</dc:creator>
<dc:date>2023-07-10</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Person-Centered Models for Cardiovascular Care: A Review of the Evidence: A Scientific Statement From the American Heart Association</dc:title>
<dc:identifier>pmid:37427418</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001141</dc:identifier>
</item>
<item>
<title>Development of an α-synuclein positron emission tomography tracer for imaging synucleinopathies</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37421950/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230711003245&amp;v=2.17.9.post6+86293ac
      <description>Synucleinopathies are characterized by the accumulation of α-synuclein (α-Syn) aggregates in the brain. Positron emission tomography (PET) imaging of synucleinopathies requires radiopharmaceuticals that selectively bind α-Syn deposits. We report the identification of a brain permeable and rapid washout PET tracer [^(18)F]-F0502B, which shows high binding affinity for α-Syn, but not for Aβ or Tau fibrils, and preferential binding to α-Syn aggregates in the brain sections. Employing several cycles...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Jun 27:S0092-8674(23)00644-X. doi: 10.1016/j.cell.2023.06.004. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Synucleinopathies are characterized by the accumulation of α-synuclein (α-Syn) aggregates in the brain. Positron emission tomography (PET) imaging of synucleinopathies requires radiopharmaceuticals that selectively bind α-Syn deposits. We report the identification of a brain permeable and rapid washout PET tracer [<sup>18</sup>F]-F0502B, which shows high binding affinity for α-Syn, but not for Aβ or Tau fibrils, and preferential binding to α-Syn aggregates in the brain sections. Employing several cycles of counter screenings with in vitro fibrils, intraneuronal aggregates, and neurodegenerative disease brain sections from several mice models and human subjects, [<sup>18</sup>F]-F0502B images α-Syn deposits in the brains of mouse and non-human primate PD models. We further determined the atomic structure of the α-Syn fibril-F0502B complex by cryo-EM and revealed parallel diagonal stacking of F0502B on the fibril surface through an intense noncovalent bonding network via inter-ligand interactions. Therefore, [<sup>18</sup>F]-F0502B is a promising lead compound for imaging aggregated α-Syn in synucleinopathies.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37421950/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230711003245&v=2.17.9.post6+86293ac">37421950</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.06.004>10.1016/j.cell.2023.06.004</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37421950</guid>
<pubDate>Sat, 08 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>Jie Xiang</dc:creator>
<dc:creator>Youqi Tao</dc:creator>
<dc:creator>Yiyuan Xia</dc:creator>
<dc:creator>Shilin Luo</dc:creator>
<dc:creator>Qinyue Zhao</dc:creator>
<dc:creator>Bowei Li</dc:creator>
<dc:creator>Xiaoqian Zhang</dc:creator>
<dc:creator>Yunpeng Sun</dc:creator>
<dc:creator>Wencheng Xia</dc:creator>
<dc:creator>Mingming Zhang</dc:creator>
<dc:creator>Seong Su Kang</dc:creator>
<dc:creator>Eun-Hee Ahn</dc:creator>
<dc:creator>Xia Liu</dc:creator>
<dc:creator>Fang Xie</dc:creator>
<dc:creator>Yihui Guan</dc:creator>
<dc:creator>Jenny J Yang</dc:creator>
<dc:creator>Lihong Bu</dc:creator>
<dc:creator>Shengxi Wu</dc:creator>
<dc:creator>Xiaochuan Wang</dc:creator>
<dc:creator>Xuebing Cao</dc:creator>
<dc:creator>Cong Liu</dc:creator>
<dc:creator>Zhentao Zhang</dc:creator>
<dc:creator>Dan Li</dc:creator>
<dc:creator>Keqiang Ye</dc:creator>
<dc:date>2023-07-08</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Development of an α-synuclein positron emission tomography tracer for imaging synucleinopathies</dc:title>
<dc:identifier>pmid:37421950</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.06.004</dc:identifier>
</item>
<item>
<title>TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37421949/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230711003245&amp;v=2.17.9.post6+86293ac
      <description>SARS-CoV-2 is associated with broad tissue tropism, a characteristic often determined by the availability of entry receptors on host cells. Here, we show that TMEM106B, a lysosomal transmembrane protein, can serve as an alternative receptor for SARS-CoV-2 entry into angiotensin-converting enzyme 2 (ACE2)-negative cells. Spike substitution E484D increased TMEM106B binding, thereby enhancing TMEM106B-mediated entry. TMEM106B-specific monoclonal antibodies blocked SARS-CoV-2 infection,...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Jul 3:S0092-8674(23)00645-1. doi: 10.1016/j.cell.2023.06.005. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">SARS-CoV-2 is associated with broad tissue tropism, a characteristic often determined by the availability of entry receptors on host cells. Here, we show that TMEM106B, a lysosomal transmembrane protein, can serve as an alternative receptor for SARS-CoV-2 entry into angiotensin-converting enzyme 2 (ACE2)-negative cells. Spike substitution E484D increased TMEM106B binding, thereby enhancing TMEM106B-mediated entry. TMEM106B-specific monoclonal antibodies blocked SARS-CoV-2 infection, demonstrating a role of TMEM106B in viral entry. Using X-ray crystallography, cryogenic electron microscopy (cryo-EM), and hydrogen-deuterium exchange mass spectrometry (HDX-MS), we show that the luminal domain (LD) of TMEM106B engages the receptor-binding motif of SARS-CoV-2 spike. Finally, we show that TMEM106B promotes spike-mediated syncytium formation, suggesting a role of TMEM106B in viral fusion. Together, our findings identify an ACE2-independent SARS-CoV-2 infection mechanism that involves cooperative interactions with the receptors heparan sulfate and TMEM106B.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37421949/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230711003245&v=2.17.9.post6+86293ac">37421949</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.06.005>10.1016/j.cell.2023.06.005</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37421949</guid>
<pubDate>Sat, 08 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>Jim Baggen</dc:creator>
<dc:creator>Maarten Jacquemyn</dc:creator>
<dc:creator>Leentje Persoons</dc:creator>
<dc:creator>Els Vanstreels</dc:creator>
<dc:creator>Valerie E Pye</dc:creator>
<dc:creator>Antoni G Wrobel</dc:creator>
<dc:creator>Valeria Calvaresi</dc:creator>
<dc:creator>Stephen R Martin</dc:creator>
<dc:creator>Chloë Roustan</dc:creator>
<dc:creator>Nora B Cronin</dc:creator>
<dc:creator>Eamonn Reading</dc:creator>
<dc:creator>Hendrik Jan Thibaut</dc:creator>
<dc:creator>Thomas Vercruysse</dc:creator>
<dc:creator>Piet Maes</dc:creator>
<dc:creator>Frederik De Smet</dc:creator>
<dc:creator>Angie Yee</dc:creator>
<dc:creator>Toey Nivitchanyong</dc:creator>
<dc:creator>Marina Roell</dc:creator>
<dc:creator>Natalia Franco-Hernandez</dc:creator>
<dc:creator>Herve Rhinn</dc:creator>
<dc:creator>Alusha Andre Mamchak</dc:creator>
<dc:creator>Maxime Ah Young-Chapon</dc:creator>
<dc:creator>Eric Brown</dc:creator>
<dc:creator>Peter Cherepanov</dc:creator>
<dc:creator>Dirk Daelemans</dc:creator>
<dc:date>2023-07-08</dc:date>
<dc:source>Cell</dc:source>
<dc:title>TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry</dc:title>
<dc:identifier>pmid:37421949</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.06.005</dc:identifier>
</item>
<item>
<title>Effective membrane tension: A long-range integrator of cellular dynamics</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37419084/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230711003245&amp;v=2.17.9.post6+86293ac
      <description>Membrane tension has been proposed to mechanically couple processes along the cell's boundary. In this issue of Cell, De Belly et al. show that local protrusion or contraction elicit a global membrane tension increase within seconds, whereas tension perturbations that engage only the membrane remain localized.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Jul 6;186(14):2956-2958. doi: 10.1016/j.cell.2023.05.033.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Membrane tension has been proposed to mechanically couple processes along the cell's boundary. In this issue of Cell, De Belly et al. show that local protrusion or contraction elicit a global membrane tension increase within seconds, whereas tension perturbations that engage only the membrane remain localized.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37419084/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230711003245&v=2.17.9.post6+86293ac">37419084</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.05.033>10.1016/j.cell.2023.05.033</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37419084</guid>
<pubDate>Fri, 07 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>Kinneret Keren</dc:creator>
<dc:date>2023-07-07</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Effective membrane tension: A long-range integrator of cellular dynamics</dc:title>
<dc:identifier>pmid:37419084</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.05.033</dc:identifier>
</item>
<item>
<title>The scientific director: A complimentary model for academic leadership</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37419083/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230711003245&amp;v=2.17.9.post6+86293ac
      <description>The current model for academic leadership places unique demands on scientists with highly active research programs. A complimentary model with a dedicated scientific director could remove this strain and allow a greater institutional investment in the community via a partnership. This article explores the rationale and framework of this model.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Jul 6;186(14):2951-2955. doi: 10.1016/j.cell.2023.05.036.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The current model for academic leadership places unique demands on scientists with highly active research programs. A complimentary model with a dedicated scientific director could remove this strain and allow a greater institutional investment in the community via a partnership. This article explores the rationale and framework of this model.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37419083/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230711003245&v=2.17.9.post6+86293ac">37419083</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.05.036>10.1016/j.cell.2023.05.036</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37419083</guid>
<pubDate>Fri, 07 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>Caroline Hendry</dc:creator>
<dc:creator>Antonio J Giraldez</dc:creator>
<dc:date>2023-07-07</dc:date>
<dc:source>Cell</dc:source>
<dc:title>The scientific director: A complimentary model for academic leadership</dc:title>
<dc:identifier>pmid:37419083</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.05.036</dc:identifier>
</item>
<item>
<title>Focus on ischaemic heart disease: from mechanisms to prevention and treatment</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37418309/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230711003245&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Jul 7;44(26):2351-2354. doi: 10.1093/eurheartj/ehad422.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37418309/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230711003245&v=2.17.9.post6+86293ac">37418309</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad422>10.1093/eurheartj/ehad422</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37418309</guid>
<pubDate>Fri, 07 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>Filippo Crea</dc:creator>
<dc:date>2023-07-07</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Focus on ischaemic heart disease: from mechanisms to prevention and treatment</dc:title>
<dc:identifier>pmid:37418309</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad422</dc:identifier>
</item>
<item>
<title>Graft Failure After Coronary Artery Bypass Grafting and Its Association With Patient Characteristics and Clinical Events: A Pooled Individual Patient Data Analysis of Clinical Trials With Imaging Follow-Up</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37417248/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230711003245&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: In contemporary practice, graft failure remains common among patients undergoing CABG and is strongly associated with adverse cardiac events.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Jul 7. doi: 10.1161/CIRCULATIONAHA.123.064090. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Graft patency is the postulated mechanism for the benefits of coronary artery bypass grafting (CABG). However, systematic graft imaging assessment after CABG is rare, and there is a lack of contemporary data on the factors associated with graft failure and on the association between graft failure and clinical events after CABG.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: We pooled individual patient data from randomized clinical trials with systematic CABG graft imaging to assess the incidence of graft failure and its association with clinical risk factors. The primary outcome was the composite of myocardial infarction or repeat revascularization occurring after CABG and before imaging. A 2-stage meta-analytic approach was used to evaluate the association between graft failure and the primary outcome. We also assessed the association between graft failure and myocardial infarction, repeat revascularization, or all-cause death occurring after imaging.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Seven trials were included comprising 4413 patients (mean age, 64.4±9.1 years; 777 [17.6%] women; 3636 [82.4%] men) and 13 163 grafts (8740 saphenous vein grafts and 4423 arterial grafts). The median time to imaging was 1.02 years (Q1;Q3: 1.00;1.03). Graft failure occurred in 1487 (33.7%) patients and in 2190 (16.6%) grafts. Age (adjusted odds ratio [aOR], 1.08 [per 10-year increment] [95% CI, 1.01-1.15]; <i>P</i>=0.03), female sex (aOR, 1.27 [95% CI, 1.08-1.50]; <i>P</i>=0.004), and smoking (aOR, 1.20 [95% CI, 1.04-1.38]; <i>P</i>=0.01) were independently associated with graft failure, whereas statins were associated with a protective effect (aOR, 0.74 [95% CI, 0.63-0.88]; <i>P</i>&lt;0.001). Graft failure was associated with an increased risk of myocardial infarction or repeat revascularization occurring between CABG and imaging assessment (8.0% in patients with graft failure versus 1.7% in patients without graft failure; aOR, 3.98 [95% CI, 3.54-4.47]; <i>P</i>&lt;0.001). Graft failure was also associated with an increased risk of myocardial infarction or repeat revascularization occurring after imaging (7.8% versus 2.0%; aOR, 2.59 [95% CI, 1.86-3.62]; <i>P</i>&lt;0.001). All-cause death after imaging occurred more frequently in patients with graft failure compared with patients without graft failure (11.0% versus 2.1%; aOR, 2.79 [95% CI, 2.01-3.89]; <i>P</i>&lt;0.001).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: In contemporary practice, graft failure remains common among patients undergoing CABG and is strongly associated with adverse cardiac events.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37417248/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230711003245&v=2.17.9.post6+86293ac">37417248</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064090>10.1161/CIRCULATIONAHA.123.064090</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37417248</guid>
<pubDate>Fri, 07 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>Mario Gaudino</dc:creator>
<dc:creator>Sigrid Sandner</dc:creator>
<dc:creator>Kevin R An</dc:creator>
<dc:creator>Arnaldo Dimagli</dc:creator>
<dc:creator>Antonino Di Franco</dc:creator>
<dc:creator>Katia Audisio</dc:creator>
<dc:creator>Lamia Harik</dc:creator>
<dc:creator>Roberto Perezgrovas-Olaria</dc:creator>
<dc:creator>Giovanni Soletti</dc:creator>
<dc:creator>Stephen E Fremes</dc:creator>
<dc:creator>David L Hare</dc:creator>
<dc:creator>Alexander Kulik</dc:creator>
<dc:creator>Andre Lamy</dc:creator>
<dc:creator>Joyce Peper</dc:creator>
<dc:creator>Marc Ruel</dc:creator>
<dc:creator>Jurrien M Ten Berg</dc:creator>
<dc:creator>Laura M Willemsen</dc:creator>
<dc:creator>Qiang Zhao</dc:creator>
<dc:creator>Daniel M Wojdyla</dc:creator>
<dc:creator>Deepak L Bhatt</dc:creator>
<dc:creator>John H Alexander</dc:creator>
<dc:creator>Bjorn Redfors</dc:creator>
<dc:date>2023-07-07</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Graft Failure After Coronary Artery Bypass Grafting and Its Association With Patient Characteristics and Clinical Events: A Pooled Individual Patient Data Analysis of Clinical Trials With Imaging Follow-Up</dc:title>
<dc:identifier>pmid:37417248</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.064090</dc:identifier>
</item>
<item>
<title>Identifying nutritional priorities for global health: time for a more PURE focus on protective foods</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37414412/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230711003245&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Jul 6:ehad325. doi: 10.1093/eurheartj/ehad325. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37414412/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230711003245&v=2.17.9.post6+86293ac">37414412</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad325>10.1093/eurheartj/ehad325</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37414412</guid>
<pubDate>Thu, 06 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>Dariush Mozaffarian</dc:creator>
<dc:date>2023-07-06</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Identifying nutritional priorities for global health: time for a more PURE focus on protective foods</dc:title>
<dc:identifier>pmid:37414412</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad325</dc:identifier>
</item>
<item>
<title>Diet, cardiovascular disease, and mortality in 80 countries</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37414411/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230711003245&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSION: A diet comprised of higher amounts of fruit, vegetables, nuts, legumes, fish, and whole-fat dairy is associated with lower CVD and mortality in all world regions, especially in countries with lower income where consumption of these foods is low.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Jul 6:ehad269. doi: 10.1093/eurheartj/ehad269. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIMS: To develop a healthy diet score that is associated with health outcomes and is globally applicable using data from the Prospective Urban Rural Epidemiology (PURE) study and replicate it in five independent studies on a total of 245 000 people from 80 countries.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS AND RESULTS: A healthy diet score was developed in 147 642 people from the general population, from 21 countries in the PURE study, and the consistency of the associations of the score with events was examined in five large independent studies from 70 countries. The healthy diet score was developed based on six foods each of which has been associated with a significantly lower risk of mortality [i.e. fruit, vegetables, nuts, legumes, fish, and dairy (mainly whole-fat); range of scores, 0-6]. The main outcome measures were all-cause mortality and major cardiovascular events [cardiovascular disease (CVD)]. During a median follow-up of 9.3 years in PURE, compared with a diet score of ≤1 points, a diet score of ≥5 points was associated with a lower risk of mortality [hazard ratio (HR) 0.70; 95% confidence interval (CI) 0.63-0.77)], CVD (HR 0.82; 0.75-0.91), myocardial infarction (HR 0.86; 0.75-0.99), and stroke (HR 0.81; 0.71-0.93). In three independent studies in vascular patients, similar results were found, with a higher diet score being associated with lower mortality (HR 0.73; 0.66-0.81), CVD (HR 0.79; 0.72-0.87), myocardial infarction (HR 0.85; 0.71-0.99), and a non-statistically significant lower risk of stroke (HR 0.87; 0.73-1.03). Additionally, in two case-control studies, a higher diet score was associated with lower first myocardial infarction [odds ratio (OR) 0.72; 0.65-0.80] and stroke (OR 0.57; 0.50-0.65). A higher diet score was associated with a significantly lower risk of death or CVD in regions with lower than with higher gross national incomes (P for heterogeneity &lt;0.0001). The PURE score showed slightly stronger associations with death or CVD than several other common diet scores (P &lt; 0.001 for each comparison).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: A diet comprised of higher amounts of fruit, vegetables, nuts, legumes, fish, and whole-fat dairy is associated with lower CVD and mortality in all world regions, especially in countries with lower income where consumption of these foods is low.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37414411/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230711003245&v=2.17.9.post6+86293ac">37414411</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad269>10.1093/eurheartj/ehad269</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37414411</guid>
<pubDate>Thu, 06 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>Andrew Mente</dc:creator>
<dc:creator>Mahshid Dehghan</dc:creator>
<dc:creator>Sumathy Rangarajan</dc:creator>
<dc:creator>Martin O'Donnell</dc:creator>
<dc:creator>Weihong Hu</dc:creator>
<dc:creator>Gilles Dagenais</dc:creator>
<dc:creator>Andreas Wielgosz</dc:creator>
<dc:creator>Scott A Lear</dc:creator>
<dc:creator>Li Wei</dc:creator>
<dc:creator>Rafael Diaz</dc:creator>
<dc:creator>Alvaro Avezum</dc:creator>
<dc:creator>Patricio Lopez-Jaramillo</dc:creator>
<dc:creator>Fernando Lanas</dc:creator>
<dc:creator>Sumathi Swaminathan</dc:creator>
<dc:creator>Manmeet Kaur</dc:creator>
<dc:creator>K Vijayakumar</dc:creator>
<dc:creator>Viswanathan Mohan</dc:creator>
<dc:creator>Rajeev Gupta</dc:creator>
<dc:creator>Andrzej Szuba</dc:creator>
<dc:creator>Romaina Iqbal</dc:creator>
<dc:creator>Rita Yusuf</dc:creator>
<dc:creator>Noushin Mohammadifard</dc:creator>
<dc:creator>Rasha Khatib</dc:creator>
<dc:creator>Nafiza Mat Nasir</dc:creator>
<dc:creator>Kubilay Karsidag</dc:creator>
<dc:creator>Annika Rosengren</dc:creator>
<dc:creator>Afzalhussein Yusufali</dc:creator>
<dc:creator>Edelweiss Wentzel-Viljoen</dc:creator>
<dc:creator>Jephat Chifamba</dc:creator>
<dc:creator>Antonio Dans</dc:creator>
<dc:creator>Khalid F Alhabib</dc:creator>
<dc:creator>Karen Yeates</dc:creator>
<dc:creator>Koon Teo</dc:creator>
<dc:creator>Hertzel C Gerstein</dc:creator>
<dc:creator>Salim Yusuf</dc:creator>
<dc:date>2023-07-06</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Diet, cardiovascular disease, and mortality in 80 countries</dc:title>
<dc:identifier>pmid:37414411</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad269</dc:identifier>
</item>
<item>
<title>Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37413990/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230711003245&amp;v=2.17.9.post6+86293ac
      <description>Chimeric antigen receptor (CAR) T cell therapy effectively treats human cancer, but the loss of the antigen recognized by the CAR poses a major obstacle. We found that in vivo vaccine boosting of CAR T cells triggers the engagement of the endogenous immune system to circumvent antigen-negative tumor escape. Vaccine-boosted CAR T promoted dendritic cell (DC) recruitment to tumors, increased tumor antigen uptake by DCs, and elicited the priming of endogenous anti-tumor T cells. This process was...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Jun 28:S0092-8674(23)00642-6. doi: 10.1016/j.cell.2023.06.002. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Chimeric antigen receptor (CAR) T cell therapy effectively treats human cancer, but the loss of the antigen recognized by the CAR poses a major obstacle. We found that in vivo vaccine boosting of CAR T cells triggers the engagement of the endogenous immune system to circumvent antigen-negative tumor escape. Vaccine-boosted CAR T promoted dendritic cell (DC) recruitment to tumors, increased tumor antigen uptake by DCs, and elicited the priming of endogenous anti-tumor T cells. This process was accompanied by shifts in CAR T metabolism toward oxidative phosphorylation (OXPHOS) and was critically dependent on CAR-T-derived IFN-γ. Antigen spreading (AS) induced by vaccine-boosted CAR T enabled a proportion of complete responses even when the initial tumor was 50% CAR antigen negative, and heterogeneous tumor control was further enhanced by the genetic amplification of CAR T IFN-γ expression. Thus, CAR-T-cell-derived IFN-γ plays a critical role in promoting AS, and vaccine boosting provides a clinically translatable strategy to drive such responses against solid tumors.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37413990/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230711003245&v=2.17.9.post6+86293ac">37413990</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.06.002>10.1016/j.cell.2023.06.002</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37413990</guid>
<pubDate>Thu, 06 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>Leyuan Ma</dc:creator>
<dc:creator>Alexander Hostetler</dc:creator>
<dc:creator>Duncan M Morgan</dc:creator>
<dc:creator>Laura Maiorino</dc:creator>
<dc:creator>Ina Sulkaj</dc:creator>
<dc:creator>Charles A Whittaker</dc:creator>
<dc:creator>Alexandra Neeser</dc:creator>
<dc:creator>Ivan Susin Pires</dc:creator>
<dc:creator>Parisa Yousefpour</dc:creator>
<dc:creator>Justin Gregory</dc:creator>
<dc:creator>Kashif Qureshi</dc:creator>
<dc:creator>Jonathan Dye</dc:creator>
<dc:creator>Wuhbet Abraham</dc:creator>
<dc:creator>Heikyung Suh</dc:creator>
<dc:creator>Na Li</dc:creator>
<dc:creator>J Christopher Love</dc:creator>
<dc:creator>Darrell J Irvine</dc:creator>
<dc:date>2023-07-06</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity</dc:title>
<dc:identifier>pmid:37413990</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.06.002</dc:identifier>
</item>
<item>
<title>Human embryo live imaging reveals nuclear DNA shedding during blastocyst expansion and biopsy</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37413989/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230711003245&amp;v=2.17.9.post6+86293ac
      <description>Proper preimplantation development is essential to assemble a blastocyst capable of implantation. Live imaging has uncovered major events driving early development in mouse embryos; yet, studies in humans have been limited by restrictions on genetic manipulation and lack of imaging approaches. We have overcome this barrier by combining fluorescent dyes with live imaging to reveal the dynamics of chromosome segregation, compaction, polarization, blastocyst formation, and hatching in the human...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Jun 28:S0092-8674(23)00643-8. doi: 10.1016/j.cell.2023.06.003. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Proper preimplantation development is essential to assemble a blastocyst capable of implantation. Live imaging has uncovered major events driving early development in mouse embryos; yet, studies in humans have been limited by restrictions on genetic manipulation and lack of imaging approaches. We have overcome this barrier by combining fluorescent dyes with live imaging to reveal the dynamics of chromosome segregation, compaction, polarization, blastocyst formation, and hatching in the human embryo. We also show that blastocyst expansion mechanically constrains trophectoderm cells, causing nuclear budding and DNA shedding into the cytoplasm. Furthermore, cells with lower perinuclear keratin levels are more prone to undergo DNA loss. Moreover, applying trophectoderm biopsy, a mechanical procedure performed clinically for genetic testing, increases DNA shedding. Thus, our work reveals distinct processes underlying human development compared with mouse and suggests that aneuploidies in human embryos may not only originate from chromosome segregation errors during mitosis but also from nuclear DNA shedding.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37413989/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230711003245&v=2.17.9.post6+86293ac">37413989</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.06.003>10.1016/j.cell.2023.06.003</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37413989</guid>
<pubDate>Thu, 06 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>Ana Domingo-Muelas</dc:creator>
<dc:creator>Robin M Skory</dc:creator>
<dc:creator>Adam A Moverley</dc:creator>
<dc:creator>Goli Ardestani</dc:creator>
<dc:creator>Oz Pomp</dc:creator>
<dc:creator>Carmen Rubio</dc:creator>
<dc:creator>Piotr Tetlak</dc:creator>
<dc:creator>Blake Hernandez</dc:creator>
<dc:creator>Eric A Rhon-Calderon</dc:creator>
<dc:creator>Luis Navarro-Sánchez</dc:creator>
<dc:creator>Carmen M García-Pascual</dc:creator>
<dc:creator>Stephanie Bissiere</dc:creator>
<dc:creator>Marisa S Bartolomei</dc:creator>
<dc:creator>Denny Sakkas</dc:creator>
<dc:creator>Carlos Simón</dc:creator>
<dc:creator>Nicolas Plachta</dc:creator>
<dc:date>2023-07-06</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Human embryo live imaging reveals nuclear DNA shedding during blastocyst expansion and biopsy</dc:title>
<dc:identifier>pmid:37413989</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.06.003</dc:identifier>
</item>
<item>
<title>Dispersal patterns and influence of air travel during the global expansion of SARS-CoV-2 variants of concern</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37413988/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230711003245&amp;v=2.17.9.post6+86293ac
      <description>The Alpha, Beta, and Gamma SARS-CoV-2 variants of concern (VOCs) co-circulated globally during 2020 and 2021, fueling waves of infections. They were displaced by Delta during a third wave worldwide in 2021, which, in turn, was displaced by Omicron in late 2021. In this study, we use phylogenetic and phylogeographic methods to reconstruct the dispersal patterns of VOCs worldwide. We find that source-sink dynamics varied substantially by VOC and identify countries that acted as global and regional...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Jun 7:S0092-8674(23)00641-4. doi: 10.1016/j.cell.2023.06.001. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The Alpha, Beta, and Gamma SARS-CoV-2 variants of concern (VOCs) co-circulated globally during 2020 and 2021, fueling waves of infections. They were displaced by Delta during a third wave worldwide in 2021, which, in turn, was displaced by Omicron in late 2021. In this study, we use phylogenetic and phylogeographic methods to reconstruct the dispersal patterns of VOCs worldwide. We find that source-sink dynamics varied substantially by VOC and identify countries that acted as global and regional hubs of dissemination. We demonstrate the declining role of presumed origin countries of VOCs in their global dispersal, estimating that India contributed &lt;15% of Delta exports and South Africa &lt;1%-2% of Omicron dispersal. We estimate that >;80 countries had received introductions of Omicron within 100 days of its emergence, associated with accelerated passenger air travel and higher transmissibility. Our study highlights the rapid dispersal of highly transmissible variants, with implications for genomic surveillance along the hierarchical airline network.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37413988/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230711003245&v=2.17.9.post6+86293ac">37413988</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC10247138/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230711003245&v=2.17.9.post6+86293ac">PMC10247138</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.06.001>10.1016/j.cell.2023.06.001</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37413988</guid>
<pubDate>Thu, 06 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>Houriiyah Tegally</dc:creator>
<dc:creator>Eduan Wilkinson</dc:creator>
<dc:creator>Joseph L-H Tsui</dc:creator>
<dc:creator>Monika Moir</dc:creator>
<dc:creator>Darren Martin</dc:creator>
<dc:creator>Anderson Fernandes Brito</dc:creator>
<dc:creator>Marta Giovanetti</dc:creator>
<dc:creator>Kamran Khan</dc:creator>
<dc:creator>Carmen Huber</dc:creator>
<dc:creator>Isaac I Bogoch</dc:creator>
<dc:creator>James Emmanuel San</dc:creator>
<dc:creator>Jenicca Poongavanan</dc:creator>
<dc:creator>Joicymara S Xavier</dc:creator>
<dc:creator>Darlan da S Candido</dc:creator>
<dc:creator>Filipe Romero</dc:creator>
<dc:creator>Cheryl Baxter</dc:creator>
<dc:creator>Oliver G Pybus</dc:creator>
<dc:creator>Richard J Lessells</dc:creator>
<dc:creator>Nuno R Faria</dc:creator>
<dc:creator>Moritz U G Kraemer</dc:creator>
<dc:creator>Tulio de Oliveira</dc:creator>
<dc:date>2023-07-06</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Dispersal patterns and influence of air travel during the global expansion of SARS-CoV-2 variants of concern</dc:title>
<dc:identifier>pmid:37413988</dc:identifier>
<dc:identifier>pmc:PMC10247138</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.06.001</dc:identifier>
</item>





























</channel>
</rss>